Muscle Relaxants 2025

  • Muscle Relaxants Overview

    • Also known as paralytic agents or neuromuscular blocking agents (NMBAs).

    • Two main types:

      • Depolarizing (DNMBAs)

      • Nondepolarizing (NDNMBA)

  • The Neuromuscular Junction (NMJ)

    • Signal propagation involves Na+ & K+ channels, leading to Ca2+ influx.

    • Acetylcholine (ACh) is released, binding nicotinic receptors to trigger muscle contraction through Ca2+ influx.

    • Acetylcholinesterase (AChE) breaks down ACh to terminate signaling.

    • Up-regulation of receptors can occur in various pathologic states, complicating anesthesia management.

  • Monitoring Neuromuscular Blockade

    • Peripheral Nerve Stimulator (Twitch Monitor):

      • Deliver electrical stimuli to monitor degree of NM blockade.

      • Train-of-Four (TOF) stimulation useful for assessing blockade depth.

      • Fade indicates presynaptic receptor antagonism, revealing the extent of paralysis.

  • Types of Muscle Relaxants

    • Succinylcholine:

      • Only currently used depolarizing agent.

      • Rapid onset (30-60 sec), ultra-short action (3-5 min).

      • Up-regulates ACh receptors in certain conditions (e.g., burns).

    • Nondepolarizing Agents (e.g., Vecuronium, Rocuronium):

      • Act as competitive antagonists at the NMJ.

      • Vary in their onset and duration, typically excreted by liver or kidneys.

  • Reversal Agents

    • Cholinesterase Inhibitors (e.g., Neostigmine):

      • Increase ACh at NMJ, reversing nondepolarizing blocks.

      • Often combined with anticholinergics (e.g., Glycopyrrolate) to reduce side effects.

    • Sugammadex:

      • Selective relaxant-binding agent for rocuronium and vecuronium.

      • Rapidly reverses muscle blockade; concerns about hypersensitivity.

    • Anticholinergic Side Effects:

      • May include dry mouth, tachycardia, and urinary retention.

  • Malignant Hyperthermia

    • Genetic predisposition triggered by certain anesthetics, including succinylcholine.

    • Symptoms: muscle rigidity, hyperthermia, metabolic acidosis.

    • Treatment: Dantrolene, cooling, and correction of metabolic abnormalities.

  • Conclusion:

    • Understanding NMJ mechanics and interventions is crucial for anesthetic management to avoid complications associated with muscle relaxants and their reversal.

Muscle Relaxants Testing Overview:

  • Purpose: Evaluate the effectiveness and safety of muscle relaxants in clinical settings.

  • Common Tests:

    • Peripheral Nerve Stimulator: Measures neuromuscular blockade by testing the muscle response to electrical stimuli.

    • Train-of-Four (TOF) Ratio: Assesses the depth of paralysis by comparing the response of muscles to four consecutive stimuli; a fade in response indicates neuromuscular blockage.

  • Importance of Monitoring: Ensures appropriate dosing and minimizes risks of adverse effects during anesthesia management.